跳至主要内容
临床试验/DRKS00005154
DRKS00005154尚未招募不适用

Observational Study for the Outcome After Discontinuing TNF Blockers in Crohn’s Disease - EXIT-TNF

German Inflammatory Bowel Diseases Study Group, c/o Kompentenznetz chronisch entzündliche Darmerkrankungen0 个研究点目标入组 90 人开始时间: 2014年3月25日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • diagnosis: Crohn's disease
  • - uninterrupted treatment with adalimumab or infliximab for at least 6 months
  • - HBI <= 3
  • - planned ending of treatment with TNF blocker
  • - last dose of TNF blocker
  • * within three weeks with adalimumb
  • * within nine weeks with infliximab

排除标准

  • - stopping of treatment because of lack of response of fistulizing disease
  • - existence of ileostomy or colostomy
  • - glucocorticoids within the last three months

研究者

发起方
German Inflammatory Bowel Diseases Study Group, c/o Kompentenznetz chronisch entzündliche Darmerkrankungen

相似试验